Greece Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
COVID-19
Dataset Records for COVID-19
Displaying 151 - 200 of 1661
Croatia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Ireland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Italy Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Lithuania Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Luxembourg Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
North Macedonia Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Malta Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Bosnia and Herzegovina Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Montenegro Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Switzerland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Poland Eurobarometer 94.3: Standard Eurobarometer 94 (COVID-19 Pandemic) 2021
ZA7780: Eurobarometer 94.3 (2021)
Survey:
Cross-sectional - Individual - Interview
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1 2021
GHDx Entry last modified on: Jun 14, 2023
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
GHDx Entry last modified on: Jan 31, 2024
El Salvador Global Youth Tobacco Survey 2021
Survey:
Cross-sectional - Facility (non-health) - Individual - Nationally representative
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022
GHDx Entry last modified on: Mar 22, 2024
Germany Digital Vaccination Rate Monitoring for COVID-19 2021-2022
Digitales Impfquotenmonitoring zur COVID-19-Impfung
Russia Natural Movement of the Population 2021
Естественное Движение Населения В Разрезе Субъектов Российской Федерации За 2021 Года
Vital registration:
Subnationally representative
United States Behavioral Risk Factor Surveillance System 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative
Seychelles Annual Health Sector Report 2021
Report:
Nationally representative
The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq
GHDx Entry last modified on: Mar 22, 2024
United States COVID-19 Data Tracker Vaccinations 2021-2022
CDC COVID Data Tracker
Administrative data:
Epi surveillance
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021
GHDx Entry last modified on: Aug 24, 2023
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
GHDx Entry last modified on: Jan 31, 2024
United Kingdom - Scottish Health Survey 2021 - Scottish Government
SHeS21
Survey:
Cross-sectional - Household - Individual - Interview
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal
GHDx Entry last modified on: Mar 22, 2024
Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq
GHDx Entry last modified on: Sep 17, 2024
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
United States National Health Interview Survey 2021
2021 NHIS
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021
GHDx Entry last modified on: Jan 31, 2024
Myanmar COVID-19 High Frequency Phone Survey (HFPS) 2021 Round 6
COVID-19 High Frequency Phone Survey 2020-2021, Myanmar, Round 6
Survey:
Household - Individual - Interview - Longitudinal - Nationally representative - Subnationally representative
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study
GHDx Entry last modified on: Mar 14, 2022
Three-month Clinical Status of A Cohort of Adult Hospitalized COVID-19 Pimpaka Srisiriwanna M.D., Poolsuk Janepanish Visudtibhan Ph.D., Kumthorn Malathum M.D
GHDx Entry last modified on: Mar 22, 2024
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
GHDx Entry last modified on: Mar 22, 2024
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study
GHDx Entry last modified on: Mar 22, 2024
Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Brazil - Tocantins COVID-19 Epidemiological Bulletin 2021
Boletim Epidemiológico Notificação para COVID-19 2021
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic. Preprint
GHDx Entry last modified on: Apr 8, 2022
Subscribe